MedTrace Logo

Clinical Trial to Evaluate the Efficacy of Smoking Cessation

NCT01538394 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 322

Last updated 2013-10-18

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of smoking cessation by using varenicline as monotherapy (VRN + placebo patches) or combined therapy (VRN + nicotine patches).

Conditions

  • Smoking Cessation

Interventions

DRUG

Varenicline

DRUG

Nicotine patches

DRUG

Placebo (nicotine patches)

Sponsors & Collaborators

  • Josep Maria Ramon Torrell, PhD

    lead OTHER

Principal Investigators

  • JOSEP M RAMON TORRELL, PhD · Hospital Universitari de Bellvitge

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538394 on ClinicalTrials.gov